查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404814

原料药市场规模、份额、趋势分析报告：按合成类型、製造商、类型、应用、药物类型、地区、细分市场预测，2024-2030

Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Type Of Synthesis (Biotech, Synthetic), By Type Of Manufacturer (Captive, Merchant), By Type, By Application, By Type Of Drug, By Region, & Segment Forecasts, 2024-2030
出版日期: | 出版商: Grand View Research | 英文 191 Pages | 商品交期: 2-10个工作天内

价格

原料原料药市场的成长与趋势：

预计2030年全球活性药物原料药市场规模将达3,529.8亿美元，2024年至2030年复合年增长率为5.75%。

该市场是由生物製药行业的成长、原料药(API) 製造的进步以及老年人口的增加所推动的。

专属式API 产业的成长将由公司投资于解决挑战和开发新的化学方法来生产自己的 API 来推动。这有助于降低成本和污染风险。人工智慧和蛋白质合成有望增强过程控制并促进更快的开发。

心血管疾病等慢性疾病和生活方式疾病的盛行率不断上升，加速了对 API 的需求。例如，根据 2020 年《美国药剂师》的调查，47% 的成年人至少有一个支持心血管疾病发展的危险因子。心血管疾病是全球主要的公共卫生负担之一，推动了该领域原料药的广泛研究和开发。

原料药市场受到了 COVID-19 大流行的正面影响，各国和主要企业生产大量成分以满足 COVID-19 治疗需求。由于大流行，製药公司改变了策略，将重点放在更大的患者群体上。例如，为了治疗冠状病毒，美国已要求从印度进口羟氯奎。该病毒也影响加拿大的药品供应系统，可能导致患者出现併发症。学名药的重要性日益增加、生物製药消费的增加以及药品生产研发活动的扩大是市场成长的主要驱动力。然而，市场扩张可能会受到一些国家不利的药品价格法规和高昂的製造成本的阻碍。

由于地缘政治条件，印度等新兴国家比中国等 API 市场主导国家更受市场青睐。此外，印度拥有优质的原材料和产品、大量的劳动力、庞大的分销网络以及政府透过「印度製造」计划提供的补贴。

公司正在合作开发新的治疗方法，以满足未满足的医疗需求。这使得公司能够利用其资源来开发产品并加强其供应链。 2021年11月，默克宣布收购Acceleron Pharma。此次收购将有助于扩大默克公司的心血管产品组合和产品线。

原料药市场报告亮点

  • 由于开发新药的研发活动增加以及政府的活性化倡议，创新原料药在 2023 年占据最大份额，为 62.0%。
  • 2023年，自有API细分市场占最大份额，达51.03%。
  • 由于原材料的高可得性和这些分子的简单合成方案，合成 API 领域在 2023 年占据市场主导地位，收益占有率最高为 70.66%。
  • 2023 年，北美地区的收益占有率最大，为 38.26%，预计在预测期内将保持领先。这是因为癌症和其他文明病的流行病学不断上升正在推动研发活动并促进市场成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素
    • 老年人口增加
    • 医院感染、遗传性疾病、心血管疾病、神经系统疾病等目标疾病盛行率上升
    • 人们对癌症治疗中的标靶治疗方法越来越感兴趣
    • API外包需求不断增加
  • 市场抑制因素分析
    • 资金投入大、生产成本大
    • 有关原料药的严格安全和处理规定
  • 营商环境分析
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
    • COVID-19感染疾病的影响分析

第 4 章：复合型业务分析

  • 原料药市场：合成类型变化分析
  • 生物原料药
  • 合成API

第五章 製造商类型业务分析

  • 原料药市场：厂商类型波动分析
  • 专属式API
  • 商家API

第六章 类型业务分析

  • 原料药药市场：类型变异分析
  • 一般API
  • 创新的API

第七章 应用业务分析

  • 原料药市场：应用变化分析
  • 心血管疾病
  • 肿瘤学
  • 中枢神经系统和神经病学
  • 整形外科
  • 内分泌学
  • 呼吸系统医疗设备
  • 消化内科
  • 肾臟病学
  • 眼科
  • 其他的

第八章 医药类业务分析

  • 原料药市场：药物变异分析的类型
  • 处方笺
  • OCT

第九章区域业务分析

  • 2023 年及 2030 年按地区分類的医药原料药市场占有率
  • 北美洲
    • 北美原料原料药市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲原料原料药市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太原料原料药市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲原料原料药市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • MEA原料原料药市场，2018-2030年
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争形势

  • 参与企业概况
  • 财务绩效
  • 参与企业
    • 市场领导者
    • 2023 年原料药市场占有率占分析
    • 公司简介
    • 策略规划
Product Code: GVR-1-68038-348-5

Active Pharmaceutical Ingredients Market Growth & Trends:

The global active pharmaceutical ingredients market size is expected to reach USD 352.98 billion by 2030, expanding at a compound annual growth rate (CAGR) of 5.75% from 2024 to 2030. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical Ingredients (API) manufacturing, and an increase in the geriatric population.

The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in-house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process.

The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field.

The active pharmaceutical Ingredients market was positively influenced by the COVID-19 pandemic, as countries and significant players produce large quantities of components to meet the demand for the treatment of COVID-19. As a result of the outbreak, drug companies have changed the companies' strategies to focus on a larger patient population. To treat coronavirus, the U.S., for example, requested that HCQ be imported from India. The virus has also impacted Canada's medicine supply system, potentially causing complications for patients. The increasing importance of generics, rise in consumption of biopharmaceuticals, and expanding drug research and development activities for drug manufacturing are the primary drivers driving the growth of the market. However, the market's expansion is likely to be hampered by unfavorable drug price control regimes in several countries and high manufacturing costs.

Developing nations like India are receiving an increased preference in the market over dominant API market countries, like China, owing to geopolitical situations. Furthermore, India has quality raw materials and products, a large workforce, a vast distribution network, and government subsidies through the "Make in India" program.

To address unmet medical needs, companies are collaborating to develop novel treatments. This allows firms to use their resources to aid in the development of products and enhance the supply chain. In November 2021, Merck & Co Inc. announced that it has acquired Acceleron Pharma, this acquisition would help Merck & Co to expand their cardiovascular portfolio and pipeline.

Active Pharmaceutical Ingredients Market Report Highlights:

  • Innovative APIs held the largest share of 62.0% in 2023, owing to increasing research and development activities for novel drug development and positive government initiatives
  • Captive APIs segment held the largest market share of 51.03% in 2023
  • The synthetic API segment dominated the market with the largest revenue share of 70.66% in 2023, owing to the higher availability of raw materials and easier protocols for the synthesis of these molecules
  • North America accounted for the largest revenue share of 38.26% in 2023 and is expected to maintain its lead over the forecast period. This is attributed to the rising epidemiology of cancer, along with other lifestyle-induced diseases, thus encouraging the R&D activities, thereby boosting the market growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. Gvr's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Increasing geriatric population
    • 3.4.2. Rising prevalence of target diseases such as hospital-acquired infections, genetic, cardiovascular, and neurological diseases
    • 3.4.3. Increasing preference for targeted therapy approach in cancer treatment
    • 3.4.4. Increasing preference for outsourcing APIs
  • 3.5. Market Restraint Analysis
    • 3.5.1. High capital investments and production cost
    • 3.5.2. Stringent Safety and handling regulations regarding APIs
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Type of Synthesis Business Analysis

  • 4.1. Active Pharmaceutical Ingredients Market: Type of Synthesis Movement Analysis
  • 4.2. Biotic APIs
    • 4.2.1. Biotic APIs Market, 2018 - 2030 (USD Billion)
      • 4.2.1.1. Biotech APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
      • 4.2.1.2. Generic APIs
      • 4.2.1.2.1. Generic APIs Market, 2018 - 2030 (USD Billion)
      • 4.2.1.3. Innovative APIs
      • 4.2.1.3.1. Innovative APIs Market, 2018 - 2030 (USD Billion)
      • 4.2.1.4. Biotech APIs Market, By Product (Revenue, USD Billion, 2018 - 2030)
      • 4.2.1.5. Monoclonal Antibodies
      • 4.2.1.5.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Billion)
      • 4.2.1.6. Hormones
      • 4.2.1.6.1. Hormones Market, 2018 - 2030 (USD Billion)
      • 4.2.1.7. Cytokines
      • 4.2.1.7.1. Cytokines Market, 2018 - 2030 (USD Billion)
      • 4.2.1.8. Recombinant Proteins
      • 4.2.1.8.1. Recombinant Proteins Market, 2018 - 2030 (USD Billion)
      • 4.2.1.9. Therapeutic Enzymes
      • 4.2.1.9.1. Therapeutic Enzymes Market, 2018 - 2030 (USD Billion)
      • 4.2.1.10. Vaccines
      • 4.2.1.10.1. Vaccines Market, 2018 - 2030 (USD Billion)
      • 4.2.1.11. Blood Factors
      • 4.2.1.11.1. Blood Factors Market, 2018 - 2030 (USD Billion)
  • 4.3. Synthetic APIs
    • 4.3.1. Synthetic APIs Market, 2018 - 2030 (USD Billion)
      • 4.3.1.1. Synthetic APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
      • 4.3.1.2. Generic APIs
      • 4.3.1.2.1. Generic APIs Market, 2018 - 2030 (USD Billion)
      • 4.3.1.3. Innovative APIs
      • 4.3.1.3.1. Innovative APIs Market, 2018 - 2030 (USD Billion)

Chapter 5. Type of Manufacturer Business Analysis

  • 5.1. Active Pharmaceutical Ingredients Market: Type of Manufacturer Movement Analysis
  • 5.2. Captive APIs
    • 5.2.1. Captive APIs Market, 2018 - 2030 (USD Billion)
  • 5.3. Merchant APIs
    • 5.3.1. Merchant APIs Market, 2018 - 2030 (USD Billion)

Chapter 6. Type Business Analysis

  • 6.1. Active Pharmaceutical Ingredients Market: Type Movement Analysis
  • 6.2. Generic APIs
    • 6.2.1. Generic APIs Market, 2018 - 2030 (USD Billion)
  • 6.3. Innovative APIs
    • 6.3.1. Innovative APIs Market, 2018 - 2030 (USD Billion)

Chapter 7. Application Business Analysis

  • 7.1. Active Pharmaceutical Ingredients Market: Application Movement Analysis
  • 7.2. Cardiovascular Diseases
    • 7.2.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Billion)
  • 7.3. Oncology
    • 7.3.1. Innovative APIs Oncology Market, 2018 - 2030 (USD Billion)
  • 7.4. CNS and Neurology
    • 7.4.1. CNS and Neurology Market, 2018 - 2030 (USD Billion)
  • 7.5. Orthopedic
    • 7.5.1. Orthopedic Market, 2018 - 2030 (USD Billion)
  • 7.6. Endocrinology
    • 7.6.1. Endocrinology Market, 2018 - 2030 (USD Billion)
  • 7.7. Pulmonology
    • 7.7.1. Pulmonology Market, 2018 - 2030 (USD Billion)
  • 7.8. Gastroenterology
    • 7.8.1. Gastroenterology Market, 2018 - 2030 (USD Billion)
  • 7.9. Nephrology
    • 7.9.1. Nephrology Market, 2018 - 2030 (USD Billion)
  • 7.10. Ophthalmology
    • 7.10.1. Ophthalmology Market, 2018 - 2030 (USD Billion)
  • 7.11. Others
    • 7.11.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 8. Type of Drug Business Analysis

  • 8.1. Active Pharmaceutical Ingredients Market: Type of Drug Movement Analysis
  • 8.2. Prescription
    • 8.2.1. Prescription Market, 2018 - 2030 (USD Billion)
      • 8.2.1.1. OTC
      • 8.2.1.2. OTC Market, 2018 - 2030 (USD Billion)

Chapter 9. Regional Business Analysis

  • 9.1. Active Pharmaceutical Ingredients Market Share By Region, 2023 & 2030
  • 9.2. North America
    • 9.2.1. North America Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Target Disease Prevalence
      • 9.2.2.3. Competitive Scenario
      • 9.2.2.4. Regulatory Framework
      • 9.2.2.5. Reimbursement Scenario
      • 9.2.2.6. U.S. Active pharmaceutical ingredients market, 2018 - 2030 (USD MILLION)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Target Disease Prevalence
      • 9.2.3.3. Competitive Scenario
      • 9.2.3.4. Regulatory Framework
      • 9.2.3.5. Reimbursement Scenario
      • 9.2.3.6. Canada Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.3. Europe
    • 9.3.1. Europe Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.3.2. Germany
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. Reimbursement Scenario
      • 9.3.2.6. Germany Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.3.3. UK
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Reimbursement Scenario
      • 9.3.3.6. UK Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Reimbursement Scenario
      • 9.3.4.6. France Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Target Disease Prevalence
      • 9.3.5.3. Competitive Scenario
      • 9.3.5.4. Regulatory Framework
      • 9.3.5.5. Reimbursement Scenario
      • 9.3.5.6. Italy Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Target Disease Prevalence
      • 9.3.6.3. Competitive Scenario
      • 9.3.6.4. Regulatory Framework
      • 9.3.6.5. Reimbursement Scenario
      • 9.3.6.6. Spain Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Target Disease Prevalence
      • 9.3.7.3. Competitive Scenario
      • 9.3.7.4. Regulatory Framework
      • 9.3.7.5. Reimbursement Scenario
      • 9.3.7.6. Denmark Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Target Disease Prevalence
      • 9.3.8.3. Competitive Scenario
      • 9.3.8.4. Regulatory Framework
      • 9.3.8.5. Reimbursement Scenario
      • 9.3.8.6. Sweden Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Target Disease Prevalence
      • 9.3.9.3. Competitive Scenario
      • 9.3.9.4. Regulatory Framework
      • 9.3.9.5. Reimbursement Scenario
      • 9.3.9.6. Norway Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. Reimbursement Scenario
      • 9.4.2.6. Japan Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Reimbursement Scenario
      • 9.4.3.6. China Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. Reimbursement Scenario
      • 9.4.4.6. India Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.5. South Korea
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Reimbursement Scenario
      • 9.4.5.6. South Korea Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.6. Australia
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Reimbursement Scenario
      • 9.4.6.6. Australia Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Reimbursement Scenario
      • 9.4.7.6. Thailand Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.5. Latin America
    • 9.5.1. Latin America Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Reimbursement Scenario
      • 9.5.2.6. Brazil Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.5.3. Mexico
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Reimbursement Scenario
      • 9.5.3.6. Mexico Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.5.4. Argentina
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. Reimbursement Scenario
      • 9.5.4.6. Argentina Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.6. MEA
    • 9.6.1. MEA Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Reimbursement Scenario
      • 9.6.2.6. South Africa Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Reimbursement Scenario
      • 9.6.3.6. Saudi Arabia Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Target Disease Prevalence
      • 9.6.4.3. Competitive Scenario
      • 9.6.4.4. Regulatory Framework
      • 9.6.4.5. Reimbursement Scenario
      • 9.6.4.6. UAE Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Target Disease Prevalence
      • 9.6.5.3. Competitive Scenario
      • 9.6.5.4. Regulatory Framework
      • 9.6.5.5. Reimbursement Scenario
      • 9.6.5.6. Kuwait Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)

Chapter 10. Competitive Landscape

  • 10.1. Participant's overview
  • 10.2. Financial performance
  • 10.3. Participant categorization
    • 10.3.1. Market Leaders
    • 10.3.2. Active Pharmaceutical Ingredients Market Share Analysis, 2023
    • 10.3.3. Company Profiles
      • 10.3.3.1. Dr. Reddy's Laboratories Ltd.
      • 10.3.3.1.1. Company Overview
      • 10.3.3.1.2. Financial Performance
      • 10.3.3.1.3. Product Benchmarking
      • 10.3.3.1.4. Strategic Initiatives
      • 10.3.3.2. Sun Pharmaceutical Industries Ltd.
      • 10.3.3.2.1. Company Overview
      • 10.3.3.2.2. Financial Performance
      • 10.3.3.2.3. Product Benchmarking
      • 10.3.3.2.4. Strategic Initiatives
      • 10.3.3.3. Teva Pharmaceutical Industries Ltd.
      • 10.3.3.3.1. Company Overview
      • 10.3.3.3.2. Financial Performance
      • 10.3.3.3.3. Product Benchmarking
      • 10.3.3.3.4. Strategic Initiatives
      • 10.3.3.4. Cipla Inc.
      • 10.3.3.4.1. Company Overview
      • 10.3.3.4.2. Financial Performance
      • 10.3.3.4.3. Product Benchmarking
      • 10.3.3.4.4. Strategic Initiatives
      • 10.3.3.5. AbbVie Inc.
      • 10.3.3.5.1. Company Overview
      • 10.3.3.5.2. Financial Performance
      • 10.3.3.5.3. Product Benchmarking
      • 10.3.3.5.4. Strategic Initiatives
      • 10.3.3.6. Aurobindo Pharma
      • 10.3.3.6.1. Company Overview
      • 10.3.3.6.2. Financial Performance
      • 10.3.3.6.3. Product Benchmarking
      • 10.3.3.6.4. Strategic Initiatives
      • 10.3.3.7. Sandoz International GmbH (Novartis AG)
      • 10.3.3.7.1. Company Overview
      • 10.3.3.7.2. Financial Performance
      • 10.3.3.7.3. Product Benchmarking
      • 10.3.3.7.4. Strategic Initiatives
      • 10.3.3.8. Viatris Inc.
      • 10.3.3.8.1. Company Overview
      • 10.3.3.8.2. Financial Performance
      • 10.3.3.8.3. Product Benchmarking
      • 10.3.3.8.4. Strategic Initiatives
      • 10.3.3.9. Fresenius Kabi AG
      • 10.3.3.9.1. Company Overview
      • 10.3.3.9.2. Financial Performance
      • 10.3.3.9.3. Product Benchmarking
      • 10.3.3.9.4. Strategic Initiatives
      • 10.3.3.10. STADA Arzneimittel AG
      • 10.3.3.10.1. Company Overview
      • 10.3.3.10.2. Financial Performance
      • 10.3.3.10.3. Product Benchmarking
      • 10.3.3.10.4. Strategic Initiatives
    • 10.3.4. Strategy Mapping
      • 10.3.4.1. Expansion
      • 10.3.4.2. Acquisition
      • 10.3.4.3. Collaborations
      • 10.3.4.4. Disease Type/Drug Class Launch
      • 10.3.4.5. Partnerships
      • 10.3.4.6. Others

List of Tables

  • Table 1 List of Tables
  • Table 2 Global Active Pharmaceutical Ingredients Market, By Region, 2018 - 2030 (USD Billion)
  • Table 3 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 4 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 5 Global Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 6 Global Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 7 Global Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 8 North America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
  • Table 9 North America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 10 North America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 11 North America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 12 North America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 13 North America Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 14 U.S. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 15 U.S. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 16 U.S. Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 17 U.S. Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 18 U.S. Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 19 Canada Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 20 Canada Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 21 Canada Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 22 Canada Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 23 Canada Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 24 Europe Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
  • Table 25 Europe Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 26 Europe Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 27 Europe Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 28 Europe Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 29 Europe Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 30 UK Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 31 UK Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 32 UK Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 33 UK Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 34 UK Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 35 Germany Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 36 Germany Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 37 Germany Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 38 Germany Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 39 Germany Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 40 France Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 41 France Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 42 France Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 43 France Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 44 France Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 45 Italy Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 46 Italy Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 47 Italy Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 48 Italy Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 49 Italy Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 50 Spain Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 51 Spain Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 52 Spain Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 53 Spain Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 54 Spain Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 55 Denmark Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 56 Denmark Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 57 Denmark Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 58 Denmark Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 59 Denmark Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 60 Sweden Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 61 Sweden Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 62 Sweden Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 63 Sweden Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 64 Sweden Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 65 Norway Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 66 Norway Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 67 Norway Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 68 Norway Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 69 Norway Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 70 Asia Pacific Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
  • Table 71 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 72 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 73 Asia Pacific Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 74 Asia Pacific Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 75 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 76 Japan Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 77 Japan Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 78 Japan Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 79 Japan Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 80 Japan Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 81 China Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 82 China Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 83 China Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 84 China Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 85 China Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 86 India Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 87 India Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 88 India Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 89 India Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 90 India Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 91 Australia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 92 Australia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 93 Australia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 94 Australia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 95 Australia Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 96 South Korea Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 97 South Korea Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 98 South Korea Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 99 South Korea Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 100 South Korea Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 101 Thailand Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 102 Thailand Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 103 Thailand Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 104 Thailand Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 105 Thailand Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 106 Latin America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
  • Table 107 Latin America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 108 Latin America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 109 Latin America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 110 Latin America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 111 Latin America Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 112 Brazil Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 113 Brazil Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 114 Brazil Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 115 Brazil Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 116 Brazil Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 117 Mexico Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 118 Mexico Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 119 Mexico Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 120 Mexico Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 121 Mexico Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 122 Argentina Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 123 Argentina Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 124 Argentina Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 125 Argentina Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 126 Argentina Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 127 Middle East & Africa Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
  • Table 128 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 129 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 130 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 131 Middle East & Africa Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 132 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 133 South Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 134 South Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 135 South Africa Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 136 South Africa Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 137 South Africa Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 138 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 139 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 140 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 141 Saudi Arabia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 142 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 143 UAE Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 144 UAE Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 145 UAE Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 146 UAE Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 147 UAE Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 148 Kuwait Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 149 Kuwait Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 150 Kuwait Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 151 Kuwait Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 152 Kuwait Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Active pharmaceutical ingredients market segmentation
  • Fig. 8 Market driver relevance analysis (Current & future impact)
  • Fig. 9 Market restraint relevance analysis (Current & future impact)
  • Fig. 10 Market challenge relevance analysis (Current & future impact)
  • Fig. 11 Penetration & growth prospect mapping
  • Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market penetration vs growth prospect mapping
  • Fig. 15 Active pharmaceutical ingredients market: Type of synthesis movement analysis
  • Fig. 16 Biotech APIs market, 2018 - 2030 (USD Billion)
  • Fig. 17 Synthetic APIs market, 2018 - 2030 (USD Billion)
  • Fig. 18 Active pharmaceutical ingredients market: Type of manufacturer movement analysis
  • Fig. 19 Captive APIs market, 2018 - 2030 (USD Billion)
  • Fig. 20 Merchant APIs market, 2018 - 2030 (USD Billion)
  • Fig. 21 Active pharmaceutical ingredients market: Type movement analysis
  • Fig. 22 Generic APIs market, 2018 - 2030 (USD Billion)
  • Fig. 23 Innovative APIs market, 2018 - 2030 (USD Billion)
  • Fig. 24 Active pharmaceutical ingredients market: Application movement analysis
  • Fig. 25 Cardiovascular diseases market, 2018 - 2030 (USD Billion)
  • Fig. 26 Oncology market, 2018 - 2030 (USD Billion)
  • Fig. 27 CNS and Neurology market, 2018 - 2030 (USD Billion)
  • Fig. 28 Orthopaedic market, 2018 - 2030 (USD Billion)
  • Fig. 29 Endocrinology market, 2018 - 2030 (USD Billion)
  • Fig. 30 Pulmonology market, 2018 - 2030 (USD Billion)
  • Fig. 31 Gastroenterology market, 2018 - 2030 (USD Billion)
  • Fig. 32 Nephrology market, 2018 - 2030 (USD Billion)
  • Fig. 33 Ophthalmology market, 2018 - 2030 (USD Billion)
  • Fig. 34 Others market, 2018 - 2030 (USD Billion)
  • Fig. 35 Active pharmaceutical ingredients market: Type of drug movement analysis
  • Fig. 36 Prescription market, 2018 - 2030 (USD Billion)
  • Fig. 37 OTC market, 2018 - 2030 (USD Billion)
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 Regional outlook, 2018 & 2030
  • Fig. 40 North America active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 41 U.S. active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 42 Canada active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 43 Europe active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 44 UK active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 45 Germany active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 46 Italy active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 47 Spain active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 48 France active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 49 Denmark active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 50 Sweden active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 51 Norway active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 52 Asia Pacific active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 53 Japan active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 54 China active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 55 India active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 56 Australia active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 57 South Korea active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 58 Thailand active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 59 Latin America active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 60 Brazil active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 61 Mexico active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 62 Argentina active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 63 MEA active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 64 South Africa active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 65 Saudi Arabia active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 66 UAE active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 67 Kuwait active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)